Editorials

Thyroid autoantibodies, preterm birth, and miscarriage

BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d2260 (Published 09 May 2011) Cite this as: BMJ 2011;342:d2260
  1. Roberto Negro, MD1,
  2. Alex Stagnaro-Green, senior associate dean for education2
  1. 1Division of Endocrinology, “V Fazzi” Hospital, 73100, Lecce, Italy
  2. 2George Washington University, School of Medicine and Health Science, Washington, DC, USA
  1. dr.negro{at}libero.it

The association is clear, but the effects of levothyroxine treatment are uncertain

In the linked systematic review (doi:10.1136/bmj.d2616), Thangaratinam and colleagues assess the association of thyroid autoantibodies with miscarriage and preterm birth in biochemically euthyroid women and the effect of levothyroxine treatment on pregnancy outcomes.1

An association between thyroid antibodies and miscarriage was first reported in 1990.2 The finding was serendipitous—the prospective study was originally designed to evaluate the incidence and causes of postpartum thyroiditis. As the study progressed, the unexpected number of spontaneous miscarriages in euthyroid women with thyroid antibodies prompted the researchers to assess pregnancy outcome in the 552 women who were initially screened in the first trimester. The rate of miscarriage in thyroid antibody positive women was twice that seen in thyroid antibody negative women (17.0% v 8.4%; P=0.01). The increased rate of pregnancy loss was not related to differences in maternal age, cardiolipin antibody status, pregnancy history, or concentration of thyroid stimulating hormone. Similarly, the initial discovery of a significant association between thyroid antibodies and preterm delivery seems to have been by …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe